Serial Number
86463776
Owner
Otsuka America Pharmaceutical, Inc.Attorney
B. Brett HeavnerFirst Use Date
Nov 24, 2014
Filing Date
Nov 24, 2014
ASSURE Trademark
Serial Number: 86463776 • Registration: 5807079
Trademark Classes
Class 36 - Insurance & Financial
Insurance; financial affairs; monetary affairs; real estate affairs
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 16 - Paper Goods
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
B. BRETT HEAVNER FINNEGAN, HENDERSON, FARABOW, GARRETT AND DUNNER,
901 NEW YORK AVE NW
WASHINGTON, DC 20001-4432
UNITED STATES
Trademark Details
Filing Date
November 24, 2014
Registration Date
July 16, 2019
First Use Anywhere
November 24, 2014
First Use in Commerce
November 24, 2014
Published for Opposition
January 31, 2017
Cancellation Date
January 30, 2026
Goods & Services
Promoting awareness of patient support offerings for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment; discharge planning support, namely, providing consumer information to patients about health care plan options, products and programs in the field of managed care and state and federal medical care programs for central nervous system diseases, disorders and treatment and for vasopressin receptor antagonist responsive diseases, disorders, and treatment
Printed materials, namely, brochures, pamphlets and posters about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment
Educational services, namely, conducting educational programs and providing courses about central nervous system diseases, disorders and treatment; on-line publishing of electronic publications; on-line journals, namely, blogs about central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment
Providing financial information about reimbursement for medical expenses for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical benefit verification and prior authorization services for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical records coding, billing, and compliance for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders
Providing patient support in the nature of information about the location of medical treatment facilities for central nervous system diseases and disorders and for vasopressin receptor antagonist responsive diseases and disorders; providing medical information to medical professionals in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders; providing a website for medical professionals featuring medical information in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders
